inotuzumab_ozogamicin  - Removal Estimates

💊 inotuzumab_ozogamicin 

inotuzumab_ozogamicin  Dialyzability By Different Modalities

MW: 146634.36
Protein Binding: 97% (cytotoxic agent)%
Vd: N/A

📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

Hemodialysis

1.6 mL/min
Poorly Dialyzable
Minimal removal expected. Half-life: 12.3 days. No supplementation needed. Despite long half-life, clearance is low due to other factors.
Data Used:
✅ protein_binding, molar_mass, mw_factor, half_life
⚠️ Missing: vd
Free fraction: 0.03 Mw factor: 0.2 Vd factor: 0.8 Hl factor: 1.2 Half life: 12.3 days Half life category: Extended (> 72h)
🫀

Peritoneal Dialysis

0.0 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 12.3 days.
Data Used:
✅ protein_binding, molar_mass, half_life
Free fraction: 0.03 Half life: 12.3 days Half life category: Extended (> 72h)
🔄

Plasmapheresis (TPE)

Potential Risk (Vd Unknown)
High protein binding suggests possible removal. Vd data needed for accurate assessment.
Data Used:
✅ protein_binding, half_life
⚠️ Missing: vd
Half life: 12.3 days Half life category: Extended (> 72h)
🧪

Hemoadsorption

Cannot Assess
Vd data required for hemoadsorption effectiveness assessment.
Data Used:
✅ half_life
⚠️ Missing: vd
Half life: 12.3 days Half life category: Extended (> 72h)

📋 Summary of Estimates

Modality Clearance/Value Half-Life Classification Data Quality
Hemodialysis 1.6 mL/min 12.3 days Poorly Dialyzable Partial Data
Peritoneal Dialysis 0.0 mL/min 12.3 days Low PD Clearance Complete Data
Plasmapheresis (TPE) Potential Risk (Vd Unknown) 12.3 days N/A Partial Data
Hemoadsorption Cannot Assess 12.3 days N/A Partial Data

📌 Important Notes

Back to Drug Details